SOURCE: ExL Pharma

May 30, 2007 11:30 ET

ExL Pharma's Adaptive Trial Designs Increase Probability of Clinical Success, Over 7 Supporting Case Study Examples Presented in July

NEW YORK, NY--(Marketwire - May 30, 2007) - ExL Pharma's 2nd Trial Design Innovation Conference, Accelerating Safer Drug Development with Adaptive Trials, attracts the pharmaceutical and biotech industry's leading clinical decision-makers on July 16-17 at the Sheraton Crystal City in Arlington, VA.

The inaugural 2006 event featured the widely quoted keynote presentation by Dr. Scott Gottlieb as FDA Deputy Commissioner and triggered industry-wide recognition of the benefits of adaptive trial designs. The 2nd Trial Design Innovation conference promises to again be the forum for industry visionaries spearheading the movement towards adaptive trials to share experiences, case studies and strategize on what lies ahead.

Featured speakers include:

--  Robert R. Ruffolo, Jr, PhD, President, R&D, Wyeth
--  Stuart Pocock, PhD, Medical Statistics Unit, London School of Hygiene
    and Tropical Medicine
--  Mike Krams, MD, Vice President, Adaptive Trials, Wyeth
--  Steve Pascoe, MD, MSc, Global Head, Respiratory/Dermatology Profiling
    Exploratory Clinical Development, Novartis
--  Jerald Schindler, DrPH, Vice President, Late-Stage Clinical
    Development Statistics, Merck
--  Michael Wolf, Director, Site Head - Oncology Therapeutics, Clinical
    Development Biostatistics, Amgen
--  Andrew Stone, Therapeutic Statistical Expert, Oncology & Infection,
    AstraZeneca
--  P.K. Tandon, PhD, Senior Vice President, Biomedical Operations,
    Genzyme
    
Case study presentations from Wyeth, Novartis, Amgen, AstraZeneca, Genentech, Cytel and Genzyme.

This event is produced by ExL Pharma and supported by Axio Research, ClinPhone, Cmed, Cytel Inc., Decision Biomarkers, Information Mediary Corporation (IMC), Medidata Solutions, Tessella & United Biosource Corporation (UBC).

For more information and to download a conference brochure please go to http://www.exlpharma.com/eventDetail.php?id=77

Contact: Kristen Hunter at 212-400-6241 or khunter@exlpharma.com

To register to attend this conference please call 888-207-6528 or visit http://www.exlpharma.com/eventRegister.php?id=77

Prices increase after June 1st. To receive a 5% discount use Registration and Discount Code: P415PR

About ExL Pharma

ExL Pharma, a division of ExL Events, Inc., is an emerging leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.

Contact Information